Electra Therapeutics adopts amended, restated bylaws effective at IPO close

Electra Therapeutics adopted amended and restated bylaws effective Sept. 21, 2026, in connection with its IPO closing. The changes took effect alongside an amended and restated certificate of incorporation filed in Delaware on the same date. The IPO closed Sept. 21, 2026, with 23,333,334 common shares sold at USD 15 per share, raising about USD 350 million gross.